These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 19092340
1. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, Bonaccorsi-Riani E, Vanthuyne V, Hetsch N, Roggen F, Reyck CD, Goffette P, Latinne D, Orlando G, Rahier J, Sempoux C, Wallemacq P, Laterre PF, Gianello P. Ann Surg; 2008 Dec; 248(6):956-67. PubMed ID: 19092340 [Abstract] [Full Text] [Related]
2. Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center. Foroncewicz B, Mucha K, Ryszkowska E, Ciszek M, Ziółkowski J, Porowski D, Krawczyk M, Paczek L. Transplant Proc; 2009 Oct; 41(8):3103-6. PubMed ID: 19857686 [Abstract] [Full Text] [Related]
3. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients. Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M. Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523 [Abstract] [Full Text] [Related]
4. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. Lerut JP, Pinheiro RS, Lai Q, Stouffs V, Orlando G, Juri JM, Ciccarelli O, Sempoux C, Roggen FM, De Reyck C, Latinne D, Gianello P. Ann Surg; 2014 Nov; 260(5):886-91; discussion 891-2. PubMed ID: 25379858 [Abstract] [Full Text] [Related]
12. Early cyclosporine monotherapy in liver transplantation: a 5-year follow-up of a prospective, randomized trial. Belli LS, de Carlis L, Rondinara G, Alberti AB, Bellati G, De Gasperi A, Forti D, Idèo G. Hepatology; 1998 Jun; 27(6):1524-9. PubMed ID: 9620322 [Abstract] [Full Text] [Related]
14. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM. Clin Transplant; 2006 Jun; 20(2):211-20. PubMed ID: 16640529 [Abstract] [Full Text] [Related]
15. Impact of steroid-avoidance immunosuppression on long-term outcome after liver transplantation for HCV cirrhosis: the need for well documented long-term follow-up. Bonaccorsi-Riani E, Sempoux C, Piette N, Julliard O, Kabamba B, Ciccarelli O, Roggen F, De Reyck C, Hassoun Z, Lerut J. Acta Gastroenterol Belg; 2012 Dec; 75(4):411-8. PubMed ID: 23402084 [Abstract] [Full Text] [Related]